STAT+: Duke scientists seemed to have developed a ‘Holy Grail’ of cancer treatment. Then the truth came out
A fraudulent cancer breakthrough, a test for the future president of MIT, and a new age of doubt in science.
Previous Post
The biotech bi-weekly: preserving biodiversity, engineering phage therapies, manufacturing difficult-to-express molecules and revolutionizing viticulture
Next Post
Reducing Sodium in Narcolepsy Treatment: Cardiovascular Insights From the XYLO Trial
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago